Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor

Pathobiology

Volumn 78, Issue 3, 2011, Pages 132-139

  Yamamoto, Hidetaka ^a   Kohashi, Kenichi ^a   Tsuneyoshi, Masazumi ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chromosome 22; Gastrointestinal stromal tumor; INI1; Loss of heterozygosity

Indexed keywords

CYCLIN D1; GENE PRODUCT; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER GRADING; CHROMOSOME 22Q; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INI 1 GENE; MALE; MICROSATELLITE MARKER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOMES, HUMAN, PAIR 22; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 80955173505     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000323564     Document Type: Article

References (34)

1. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-465. (Pubitemid 34747864)
2. Lasota J, Miettinen M: KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 2006;23: 91-102. (Pubitemid 44692417)
3. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580. (Pubitemid 28067289)
4. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-710. (Pubitemid 36159485)
5. Yamamoto H, Oda Y, Kawaguchi K, Nakamura N, Takahira T, Tamiya S, Saito T, Oshiro Y, Ohta M, Yao T, Tsuneyoshi M: c-kit and PDGFRA mutations in extragastro-intestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol 2004;28:479-488. (Pubitemid 38436521)
6. Fukasawa T, Chong JM, Sakurai S, Koshiishi N, Ikeno R, Tanaka A, Matsumoto Y, Hayashi Y, Koike M, Fukayama M: Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn J Cancer Res 2000;91:1241-1249. (Pubitemid 32042358)
7. Breiner JA, Meis-Kindblom J, Kindblom LG, McComb E, Liu J, Nelson M, Bridge JA: Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). Cancer Genet Cytogenet 2000;120:111-116. (Pubitemid 30609688)
8. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M: DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 2000; 60:3899-3903. (Pubitemid 32204584)
9. Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Höer J, Langer C, Schüler P, Schindler CG, Kuhlgatz J, Füzesi L: Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours. J Pathol 2004;202: 421-429. (Pubitemid 38456160)
10. Gunawan B, von Heydebreck A, Sander B, Schulten HJ, Haller F, Langer C, Armbrust T, Bollmann M, Gasparov S, Kovac D, Füzesi L: An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. J Pathol 2007; 211:463-470. (Pubitemid 46332558)
11. Lasota J, Wozniak A, Kopczynski J, Dansonka-Mieszkowska A, Wasag B, Mitsuhashi T, Sarlomo-Rikala M, Lee JR, Schneider-Stock R, Stachura J, Limon J, Miettinen M: Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Lab Invest 2005;85:237-247. (Pubitemid 40208927)
12. Pylkkänen L, Sarlomo-Rikala M, Wessman M, Hämäläinen E, Sainio M, Husgafvel-Pursiainen K, Carpén O: Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors. Hum Pathol 2003;34:872-879. (Pubitemid 37169616)
13. Schneider-Stock R, Boltze C, Lasota J, Miettinen M, Peters B, Pross M, Roessner A, Günther T: High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 2003;21:1688-1697. (Pubitemid 46638579)
14. Haller F, Gunawan B, von Heydebreck A, Schwager S, Schulten HJ, Wolf-Salgó J, Langer C, Ramadori G, Sültmann H, Füzesi L: Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin Cancer Res 2005;11: 6589-6597. (Pubitemid 41338999)
15. Haller F, Löbke C, Ruschhaupt M, Cameron S, Schulten HJ, Schwager S, von Heydebreck A, Gunawan B, Langer C, Ramadori G. Sültmann H, Poustka A, Korf U, Füzesi L: Loss of 9p leads to p16INK4A down-regulation and enables RB/E2Fl-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol 2008;215:253-262. (Pubitemid 351956706)
16. Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M: The role oflNIl and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Res 2002;62:323-328. (Pubitemid 34074022)
17. Imbalzano AN, Jones SN: Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. Cancer Cell 2005;7:294-295. (Pubitemid 40544646)
18. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O: Truncating mutations of hSNF5/INIl in aggressive paediatric cancer. Nature 1998;394:203-206. (Pubitemid 28325977)
19. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB: Alterations of the hSNF5/ INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-3467. (Pubitemid 35340722)
20. Oda Y, Tsuneyoshi M: Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other sort-tissue sarcomas with rhabdoid features. Pathol Int 2006; 56:287-295. (Pubitemid 43725396)
21. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Izumi T, Ohta S, Taguchi T, Suita S, Tsuneyoshi M: Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol 2007;133:817-824. (Pubitemid 350218907)
22. Sabah M, Cummins R, Leader M, Kay E: Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Hum Pathol 2006;37:648-655. (Pubitemid 43956544)
23. Aveyard JS, Knowles MA: Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-de-pendent probe amplification. J Mol Diagn 2004;6:356-365. (Pubitemid 39517404)
24. Yamamoto H, Tobo T, Nakamori M, Imamura M, Kojima A, Oda Y, Nakamura N, Takahira T, Yao T, Tsuneyoshi M: Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. J Cancer Res Clin Oncol 2009;135:791-798.
25. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE: Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to Gl arrest associated with induction of p16ink4a and activation of RB. Oncogene 2002;21:5193-5203. (Pubitemid 34948131)
26. Versteege I, Medjkane S, Rouillard D, Delattre O: A key role of the hSNF5/INI1 tumour suppressor in the control of the Gl-S transition of the cell cycle. Oncogene 2002;21: 6403-6412. (Pubitemid 35155445)
27. Guidi CJ, Mudhasani R, Hoover K, Koff A, Leav I, Imbalzano AN, Jones SN: Functional interaction of the retinoblastoma and Inil/ Snf5 tumor suppressors in cell growth and pituitary tumorigenesis. Cancer Res 2006; 66:8076-8082. (Pubitemid 44299173)
28. Haller F, Löbke C, Ruschhaupt M, Schulten HJ, Schwager S, Gunawan B, Armbrust T, Langer C, Ramadori G, Sültmann H, Poustka A, Korf U, Füzesi L: Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions. J Pathol 2008;216:225-235.
29. Hornick JL, Dal Cin P, Fletcher CD: Loss of INI1 expression is characteristic ofboth conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 2009;33:542-550.
30. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Oshiro Y, Izumi T, Taguchi T, Tsuneyoshi M: SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 2008; 32: 1168-1174.
31. Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA: Immunohistochemical analysis of hSNF5/INIl distinguishes renal and extrarenal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004;28:1485-1491. (Pubitemid 39425515)
32. Sigauke E, Rakheja D, Maddox DL, Hladik CL, White CL, Timmons CF, Raisanen J: Absence of expression of SM ARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol 2006;19:717-725.
33. Patil S, Perry A, Maccollin M, Dong S, Betensky RA, Yeh TH, Gutmann DH, Stemmer-Rachamimov AO: Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol 2008;18:517-519.
34. Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR: Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 2008; 74:358-366.